glp 1 triglycerides GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1R, GIPR and GCGR Cell
Description
Tirzepatide trials (SURMOUNT) demonstrated 2024% weight reduction
MacQueen and Frodl, 2011)
David Wiss explores the complex intersection of GLP-1 medications, body sovereignty, and mental health
Early indications are that the launch should be more stable than the shortages that defined the early GLP-1 surge, with supply chains better prepared and, presumably, some degree of slack in production capacity
The report details the birth of one healthy child and another pregnancy resulting in a child with an atrial septal defect, which spontaneously resolved by the age of 3 years
10.1038/nature12956 [DOI] [PMC free article] [PubMed] [Google Scholar] Krieger, J
